Detection of C1 inhibitor (SERPING1/C1NH) mutations in exon 8 in patients with hereditary angioedema: evidence for 10 novel mutations

Hereditary angioedema (HAE) is caused by mutations in the C1 inhibitor gene (SERPING1, C1NH) and the result is C1 inhibitor deficiency, either in levels or function. We have searched exon 8 for mutations by direct sequencing and analyzed the rest of the exons by SSCP in 87 Spanish families affected by HAE. Out of 87 screened families, we have detected exon 8 mutations in 26. Among these, 17 different mutations were identified: 14 point mutations and 3 frameshift. Seven of the point mutations and the three frameshift were not previously reported. Mutations were: S438P; R444P; V451G; W460X; V468D; G471E; X479R; S417fsX427; I440fsX450; E429fsX450. The rest of the families presented previously reported mutations, 5 missense and two nonsense. In none of the 26 families was an additional change identified in the rest of the exons by SSCP, and, in 20 out of the 22 families with point mutation, we verified that the mutation did not affect a healthy relative. Seven of these families had no history of the disease, and in five of them we were able to verify that the progenitors did not have the mutation. Therefore, they were de novo mutations. © 2002 Wiley–Liss, Inc.

[1]  J. Weiler,et al.  A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations. , 2001, Clinical immunology.

[2]  S. Choquet,et al.  Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema. , 2000, The Journal of allergy and clinical immunology.

[3]  B. Zuraw,et al.  Detection of C1 inhibitor mutations in patients with hereditary angioedema. , 2000, The Journal of allergy and clinical immunology.

[4]  J. Bissler,et al.  C1 Inhibitor Gene Sequence Facilitates Frameshift Mutations , 1998, Molecular medicine.

[5]  M. Tosi.  Molecular genetics of C1 inhibitor. , 1998, Immunobiology.

[6]  F. Rosen,et al.  Molecular defects in hereditary angioneurotic edema. , 1997, Proceedings of the Association of American Physicians.

[7]  E. Verpy,et al.  Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema. , 1996, American journal of human genetics.

[8]  E. Verpy,et al.  COOH-terminal Substitutions in the Serpin C1 Inhibitor That Cause Loop Overinsertion and Subsequent Multimerization (*) , 1995, The Journal of Biological Chemistry.

[9]  E. Couture-Tosi,et al.  Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function. , 1995, The Journal of clinical investigation.

[10]  K. Whaley,et al.  A point mutation in the C1-inhibitor gene causes type I hereditary angiooedema. , 1993, Human heredity.

[11]  C. Hack,et al.  Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats. , 1993, Blood.

[12]  R. Harrison,et al.  A dysfunctional Cl inhibitor protein with a new reactive center mutation (Arg‐444→Leu) , 1992, FEBS letters.

[13]  J. Bissler,et al.  C1- inhibitors and their genes: an update. , 1992, The Journal of laboratory and clinical medicine.

[14]  K. Whaley,et al.  Type II hereditary angio-oedema associated with two mutations in one allele of the C1-inhibitor gene around the reactive-site coding region. , 1992, Human heredity.

[15]  W. R. Wikoff,et al.  Substrate properties of C1 inhibitor Ma (alanine 434----glutamic acid). Genetic and structural evidence suggesting that the P12-region contains critical determinants of serine protease inhibitor/substrate status. , 1991, Journal of Biological Chemistry.

[16]  P. Carter,et al.  Complete nucleotide sequence of the gene for human C1 inhibitor with an unusually high density of Alu elements. , 1991, European journal of biochemistry.

[17]  F. Rosen,et al.  Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Carrell,et al.  Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. , 1989, Biochemistry.

[19]  K. Skriver,et al.  CpG mutations in the reactive site of human C1 inhibitor. , 1989, The Journal of biological chemistry.

[20]  J. Clegg,et al.  Haemoglobin Constant Spring has an unstable α chain messenger RNA , 1982 .

[21]  J. Clegg,et al.  Haemoglobin Constant Spring—A Chain Termination Mutant ? , 1971, Nature.

[22]  F. Rosen,et al.  Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema. , 1971, The Journal of clinical investigation.

[23]  J. Clegg,et al.  HÆMOGLOBIN-H DISEASE DUE TO A UNIQUE HÆMOGLOBIN VARIANT WITH AN ELONGATED α-CHAIN , 1971 .

[24]  F. Rosen,et al.  Hereditary Angioneurotic Edema: Two Genetic Variants , 1965, Science.